• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病发病前 10 年的住院和门诊诊断分组。

Diagnostic groups of hospital stays and outpatient visits during 10 years before Alzheimer's disease.

机构信息

Kuopio Research Center of Geriatric Care, School of Pharmacy, University of Eastern Finland, P.O. Box 1627, Kuopio, 70211, Finland.

出版信息

BMC Health Serv Res. 2023 Apr 4;23(1):339. doi: 10.1186/s12913-023-09345-3.

DOI:10.1186/s12913-023-09345-3
PMID:37016409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10074798/
Abstract

BACKGROUND

Alzheimer's disease (AD) is a major determinant of healthcare costs and increase in the healthcare service use occur already before the AD diagnosis. However, little is known how the different diagnosis categories contribute to this increase in healthcare use. We investigated how the hospitalizations and specialized healthcare outpatient visits from different diagnosis categories, based on the International Classification of Diseases (ICD-10) chapters, contribute to increased specialized healthcare service use during ten-year period preceding AD diagnosis.

METHODS

A register-based nationwide cohort of 42,934 community-dwelling persons who received clinically verified AD diagnosis in between 2008 and 2011 in Finland and 1:1 age, sex and hospital district- matched comparison cohort were included. Hospitalizations and specialized healthcare visits were categorized by the main diagnosis, according to the ICD-10 chapters. AD and dementia were separated to their own category. The number of persons with visits and stays was calculated for every 6 months, irrespective of the frequency of visits/stays individual had during that time window. Furthermore, the relative distribution of the diagnosis categories was computed.

RESULTS

AD cohort was more likely to have visits and stays during the 10-year period (OR 1.19, 95% CI 1.17-1.21). The number of persons with visits and stays peaked in AD cohort from 1.5 years before the diagnosis when the differences in relative distribution of different diagnosis categories also became evident. The largest differences were observed for visits/stays with cognitive disorders, symptoms of unspecified diseases and psychiatric disorders diagnoses, and those with missing diagnosis codes in the last time window before AD diagnosis.

CONCLUSIONS AND IMPLICATIONS

Increased healthcare service use before AD diagnosis does not seem to arise from differences in specific diagnosis categories of ICD-10 such as diseases of the circulatory system, but from the higher frequency of visits and stays among persons with AD across diagnosis categories. Based on the relative distribution of diagnosis categories, the steep increase in healthcare service use just before and during the diagnostic process is likely due to prodromal symptoms and visits related to cognition.

摘要

背景

阿尔茨海默病(AD)是医疗保健成本的主要决定因素,并且在 AD 诊断之前就已经出现了医疗保健服务使用的增加。然而,人们对不同诊断类别如何导致医疗保健使用增加知之甚少。我们研究了基于国际疾病分类(ICD-10)章节的不同诊断类别如何导致 AD 诊断前十年期间专门医疗保健服务使用的增加。

方法

该研究纳入了一个基于登记的全国队列,其中包括 42934 名居住在社区的人,他们在芬兰于 2008 年至 2011 年间接受了临床确诊的 AD 诊断,同时还纳入了 1:1 年龄、性别和医院区匹配的对照组。根据 ICD-10 章节,将住院和专门医疗保健就诊按主要诊断进行分类。将 AD 和痴呆分开到自己的类别中。无论个体在该时间段内就诊的频率如何,每 6 个月计算一次就诊人数。此外,还计算了诊断类别的相对分布。

结果

AD 队列在 10 年期间更有可能就诊和住院(OR 1.19,95%CI 1.17-1.21)。在 AD 队列中,从诊断前 1.5 年开始,就诊和住院人数达到峰值,此时不同诊断类别的相对分布差异也变得明显。在 AD 诊断前的最后一个时间窗口中,观察到最大的差异是与认知障碍、未指明疾病和精神障碍诊断相关的就诊/住院以及诊断代码缺失的就诊/住院。

结论和意义

AD 诊断前医疗保健服务使用的增加似乎不是由于 ICD-10 特定诊断类别的差异引起的,例如循环系统疾病,而是由于 AD 患者在各诊断类别中就诊和住院的频率更高。基于诊断类别的相对分布,在诊断过程前后医疗保健服务使用的急剧增加很可能是由于前驱症状和与认知相关的就诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cc7/10074798/87ac9bf5b721/12913_2023_9345_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cc7/10074798/4ee69dd2d23e/12913_2023_9345_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cc7/10074798/7c26c79d0c29/12913_2023_9345_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cc7/10074798/69a5b2147351/12913_2023_9345_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cc7/10074798/87ac9bf5b721/12913_2023_9345_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cc7/10074798/4ee69dd2d23e/12913_2023_9345_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cc7/10074798/7c26c79d0c29/12913_2023_9345_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cc7/10074798/69a5b2147351/12913_2023_9345_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cc7/10074798/87ac9bf5b721/12913_2023_9345_Fig4_HTML.jpg

相似文献

1
Diagnostic groups of hospital stays and outpatient visits during 10 years before Alzheimer's disease.阿尔茨海默病发病前 10 年的住院和门诊诊断分组。
BMC Health Serv Res. 2023 Apr 4;23(1):339. doi: 10.1186/s12913-023-09345-3.
2
Hospital admissions, outpatient visits and healthcare costs of community-dwellers with Alzheimer's disease.社区居民阿尔茨海默病患者的住院、门诊就诊和医疗费用。
Alzheimers Dement. 2015 Aug;11(8):955-63. doi: 10.1016/j.jalz.2014.10.005. Epub 2014 Dec 10.
3
Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort.芬兰全国队列中,从阿尔茨海默病诊断前五年到诊断后两年的住院治疗和药物费用。
Scand J Public Health. 2016 Mar;44(2):150-8. doi: 10.1177/1403494815614705. Epub 2015 Nov 9.
4
Shift in Hospitalizations for Alzheimer's Disease to Related Dementias in France between 2007 and 2017.2007 年至 2017 年期间法国阿尔茨海默病住院患者向相关痴呆症的转移。
J Prev Alzheimers Dis. 2019;6(2):108-111. doi: 10.14283/jpad.2019.5.
5
The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.合并症对阿尔茨海默病患者生存的影响:一项匹配队列研究。
BMC Geriatr. 2021 Mar 9;21(1):173. doi: 10.1186/s12877-021-02130-z.
6
Length of hospital stay after hip fracture and readmission rates of persons with and without Alzheimer's disease: a matched cohort study.髋部骨折后住院时间和阿尔茨海默病患者与非阿尔茨海默病患者再入院率:一项匹配队列研究。
BMC Geriatr. 2020 Jun 18;20(1):214. doi: 10.1186/s12877-020-01609-5.
7
Prevalence and characteristics of psychiatric morbidity treated in specialized health care in a nationwide cohort of people with newly diagnosed Alzheimer's disease.在一个全国性的新诊断为阿尔茨海默病患者队列中,在专门的医疗保健中治疗的精神疾病发病率和特征。
Acta Psychiatr Scand. 2022 May;145(5):507-516. doi: 10.1111/acps.13423. Epub 2022 Mar 16.
8
Risk factors of pneumonia in persons with and without Alzheimer's disease: a matched cohort study.有和无阿尔茨海默病患者肺炎的危险因素:一项匹配队列研究。
BMC Geriatr. 2023 Apr 10;23(1):227. doi: 10.1186/s12877-023-03940-z.
9
Use of physician and acute care services by persons with and without Alzheimer's disease: a population-based comparison.患有和未患阿尔茨海默病的人群对医生和急性护理服务的使用情况:基于人群的比较
J Am Geriatr Soc. 1999 Jul;47(7):864-9. doi: 10.1111/j.1532-5415.1999.tb03846.x.
10
Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.队列简介:芬兰药物与阿尔茨海默病(MEDALZ)研究
BMJ Open. 2016 Jul 13;6(7):e012100. doi: 10.1136/bmjopen-2016-012100.

引用本文的文献

1
Helicobacter pylori Eradication Treatments and Risk of Alzheimer Disease: A Case-Control Study Nested in the Finnish Population.幽门螺杆菌根除治疗与阿尔茨海默病风险:一项基于芬兰人群的病例对照研究
Epidemiology. 2025 May 1;36(3):327-333. doi: 10.1097/EDE.0000000000001831. Epub 2025 Jan 27.
2
Identifying Comorbidity Patterns in People with and without Alzheimer's Disease Using Latent Dirichlet Allocation.使用潜在狄利克雷分配法识别阿尔茨海默病患者和非阿尔茨海默病患者的共病模式。
J Alzheimers Dis. 2024;101(4):1393-1403. doi: 10.3233/JAD-240490.

本文引用的文献

1
Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study.心血管代谢性共病、遗传风险与痴呆:一项前瞻性队列研究。
Lancet Healthy Longev. 2022 Jun;3(6):e428-e436. doi: 10.1016/S2666-7568(22)00117-9.
2
Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in Whitehall II prospective cohort study.多病症发病年龄与痴呆症发病率之间的关联:Whitehall II 前瞻性队列研究 30 年随访结果。
BMJ. 2022 Feb 2;376:e068005. doi: 10.1136/bmj-2021-068005.
3
The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer's Disease.
散发性(晚发型)和遗传性阿尔茨海默病的临床及神经病理学特征
J Clin Med. 2021 Oct 3;10(19):4582. doi: 10.3390/jcm10194582.
4
Towards a Consensus on Alzheimer's Disease Comorbidity?关于阿尔茨海默病合并症的共识?
J Clin Med. 2021 Sep 24;10(19):4360. doi: 10.3390/jcm10194360.
5
A review of the mechanisms underlying selected comorbidities in Alzheimer's disease.阿尔茨海默病相关共病的潜在机制研究述评。
Pharmacol Rep. 2021 Dec;73(6):1565-1581. doi: 10.1007/s43440-021-00293-5. Epub 2021 Jun 13.
6
Multimorbidity burden and dementia risk in older adults: The role of inflammation and genetics.老年人多病共存负担与痴呆风险:炎症和遗传学的作用。
Alzheimers Dement. 2021 May;17(5):768-776. doi: 10.1002/alz.12237. Epub 2021 Jan 6.
7
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.阿尔茨海默病的临床前、前驱和痴呆阶段的持续时间与年龄、性别和 APOE 基因型有关。
Alzheimers Dement. 2019 Jul;15(7):888-898. doi: 10.1016/j.jalz.2019.04.001. Epub 2019 Jun 1.
8
Association between glaucoma and the risk of Alzheimer's disease: A systematic review of observational studies.青光眼与阿尔茨海默病风险的关联:观察性研究的系统综述。
Acta Ophthalmol. 2019 Nov;97(7):665-671. doi: 10.1111/aos.14114. Epub 2019 Apr 23.
9
Long-term medical costs of Alzheimer's disease: matched cohort analysis.阿尔茨海默病的长期医疗费用:匹配队列分析。
Eur J Health Econ. 2019 Apr;20(3):333-342. doi: 10.1007/s10198-018-1004-0. Epub 2018 Aug 31.
10
Auditory system dysfunction in Alzheimer disease and its prodromal states: A review.阿尔茨海默病及其前驱状态的听觉系统功能障碍:综述。
Ageing Res Rev. 2018 Jul;44:49-59. doi: 10.1016/j.arr.2018.04.001. Epub 2018 Apr 6.